华邦健康：公司目前形成了以医药、医疗为核心，农化、新材料、旅游三家上市公司独立发展的模式

Group 1 - The company has established a model where pharmaceutical and medical sectors are core, while agricultural chemicals, new materials, and tourism operate as independent listed companies [1] - The company plans to maintain independent and stable operations for Yingtai Biological and Kaisheng New Materials (301069), leveraging the controlling shareholder's key role in governance [1]